Pharmacological blockade of CD73 promotes anti-tumor immune responses and inhibits tumor metastasis, by reducing the accumulation of adenosine [13], and enhances the efficacy of anti-tumor agents, including anti-PD-1 or anti-CTLA-4 mAbs [29, 30]. This evidence concerns the gene CTLA4 and neoplasm.